This is a Validated Antibody Database (VAD) review about domestic r.. KRT4, based on 11 published articles (read how Labome selects the articles), using KRT4 antibody in all methods. It is aimed to help Labome visitors find the most suited KRT4 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Invitrogen
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 6b
Invitrogen KRT4 antibody (eBioscience, 53-9003-82) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 6b). Commun Biol (2022) ncbi
mouse monoclonal (AE1/AE3)
  • flow cytometry; human; loading ...
Invitrogen KRT4 antibody (eBioscience, 53-9003-82) was used in flow cytometry on human samples . Nat Commun (2021) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; rhesus macaque; 0.2 ug/ml; loading ...; fig 4g
Invitrogen KRT4 antibody (Thermo Fisher, 41-9003-82) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 0.2 ug/ml (fig 4g). Science (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 1a
Invitrogen KRT4 antibody (eBioscience, 53-9003-80) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1a). Nat Cell Biol (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; fig 4, 5
Invitrogen KRT4 antibody (eBioscience, AE1/AE3) was used in immunocytochemistry on human samples (fig 4, 5). Breast Cancer Res (2019) ncbi
mouse monoclonal (AE3)
  • flow cytometry; human; loading ...
In order to examine epithelial cell populations from touch samples, Invitrogen KRT4 antibody (eBioscience, 14-900-80) was used in flow cytometry on human samples . F1000Res (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; mouse; 1:100; loading ...; tbl 2
In order to investigate if conditioned medium from proliferating fibroblasts induce a subset of hematopoietic cells to become adherent fibroblast-like cells, Invitrogen KRT4 antibody (eBioscience, 41-9003) was used in immunocytochemistry on mouse samples at 1:100 (tbl 2). J Cell Physiol (2016) ncbi
mouse monoclonal (AE1/AE3)
  • flow cytometry; human
  • immunocytochemistry; human; 1 ul
Invitrogen KRT4 antibody (eBioscience, 53-9003-82) was used in flow cytometry on human samples and in immunocytochemistry on human samples at 1 ul. Nanomedicine (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200; fig 3
In order to study juxtacrine signaling from macrophages and monocytes and a breast cancer stem cell niche, Invitrogen KRT4 antibody (eBioscience, 53-9003-80) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3). Nat Cell Biol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; 1:100; fig 1
Invitrogen KRT4 antibody (eBioscience, AE1/AE3) was used in immunocytochemistry on human samples at 1:100 (fig 1). PLoS ONE (2013) ncbi
mouse monoclonal (AE3)
  • immunohistochemistry - paraffin section; human; 1:300; tbl 2
In order to characterize feline endometrial adenocarcinomas immunohistochemically, Invitrogen KRT4 antibody (Zymed, AE3) was used in immunohistochemistry - paraffin section on human samples at 1:300 (tbl 2). J Comp Pathol (2009) ncbi
Articles Reviewed
  1. Rodriguez E, Boelaars K, Brown K, Madunić K, van Ee T, Dijk F, et al. Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits. Commun Biol. 2022;5:41 pubmed publisher
  2. Rodriguez E, Boelaars K, Brown K, Eveline Li R, Kruijssen L, Bruijns S, et al. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9. Nat Commun. 2021;12:1270 pubmed publisher
  3. Chandrashekar A, Liu J, Martinot A, McMahan K, Mercado N, Peter L, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;: pubmed publisher
  4. Gaglia G, Rashid R, Yapp C, Joshi G, Li C, Lindquist S, et al. HSF1 phase transition mediates stress adaptation and cell fate decisions. Nat Cell Biol. 2020;22:151-158 pubmed publisher
  5. Ramani V, Lemaire C, Triboulet M, Casey K, Heirich K, Renier C, et al. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer. Breast Cancer Res. 2019;21:98 pubmed publisher
  6. Kwon Y, Stanciu C, Philpott M, Ehrhardt C. Flow cytometry dataset for cells collected from touched surfaces. F1000Res. 2016;5:390 pubmed publisher
  7. Li Y, Adomat H, Guns E, Hojabrpour P, Duronio V, Curran T, et al. Identification of a Hematopoietic Cell Dedifferentiation-Inducing Factor. J Cell Physiol. 2016;231:1350-63 pubmed publisher
  8. Muhanna N, Mepham A, Mohamadi R, Chan H, Khan T, Akens M, et al. Nanoparticle-based sorting of circulating tumor cells by epithelial antigen expression during disease progression in an animal model. Nanomedicine. 2015;11:1613-20 pubmed publisher
  9. Lu H, Clauser K, Tam W, Fröse J, Ye X, Eaton E, et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol. 2014;16:1105-17 pubmed publisher
  10. Hosokawa M, Kenmotsu H, Koh Y, Yoshino T, Yoshikawa T, Naito T, et al. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system. PLoS ONE. 2013;8:e67466 pubmed publisher
  11. Gil da Costa R, Santos M, Amorim I, Lopes C, Pereira P, Faustino A. An immunohistochemical study of feline endometrial adenocarcinoma. J Comp Pathol. 2009;140:254-9 pubmed publisher